{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:57:17Z","timestamp":1792079837699,"version":"4.4.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.euo.2025.11.007","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T21:35:57Z","timestamp":1764279357000},"page":"125-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Bladder EpiCheck triggered Photodynamic Diagnosis biopsies Detect High-grade Bladder Cancer Recurrences Missed by White Light Cystoscopy"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8221-4640","authenticated-orcid":false,"given":"Paramananthan","family":"Mariappan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Hart-Brooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Sparks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Lord-McKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.11.007_b0005","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.eururo.2024.07.027","article-title":"European Association of Urology guidelines on non\u2013muscle-invasive bladder cancer (TaT1 and carcinoma in situ)\u2014a summary of the 2024 guidelines update","volume":"86","author":"Gontero","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.11.007_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14040","article-title":"Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer","volume":"14","author":"Mowatt","year":"2010","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.euo.2025.11.007_b0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.euros.2021.06.011","article-title":"Time to turn on the blue lights: a systematic review and meta-analysis of photodynamic diagnosis for bladder cancer","volume":"31","author":"Veeratterapillay","year":"2021","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euo.2025.11.007_b0020","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.eururo.2014.06.037","article-title":"Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations","volume":"66","author":"Witjes","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.11.007_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000369357","article-title":"Molecular markers for bladder cancer screening, early diagnosis, and surveillance: the WHO\/ICUD consensus","volume":"94","author":"Schmitz-Drager","year":"2015","journal-title":"Urol Int"},{"key":"10.1016\/j.euo.2025.11.007_b0030","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/23523735241304348","article-title":"North American study and meta-analysis evaluating performance of Bladder EpiCheck\u00ae, a FDA cleared test, in non-muscle invasive bladder cancer recurrence","volume":"10","author":"Fleshner","year":"2024","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.euo.2025.11.007_b0035","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.eururo.2018.11.055","article-title":"Prospective validation of an mRNA-based urine test for surveillance of patients with bladder cancer","volume":"75","author":"Valenberg","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.11.007_b0040","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/cncy.22657","article-title":"DNA methylation analysis in urinary samples: a useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group","volume":"131","author":"Pierconti","year":"2023","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.euo.2025.11.007_b0045","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.eururo.2020.06.051","article-title":"Enhanced quality and effectiveness of transurethral resection of bladder tumour in non-muscle-invasive bladder cancer: a multicentre real-world experience from Scotland\u2019s Quality Performance Indicators programme","volume":"78","author":"Mariappan","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.11.007_b0050","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.euf.2021.07.011","article-title":"The Scottish Bladder Cancer Quality Performance Indicators Influencing Outcomes, Prognosis, and Surveillance (Scot BC Quality OPS) clinical project","volume":"7","author":"Mariappan","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2025.11.007_b0055","series-title":"Statistics with confidence: confidence intervals and statistical guidelines","author":"Altman","year":"2000"},{"key":"10.1016\/j.euo.2025.11.007_b0060","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/bju.14574","article-title":"Effect of blue-light cystoscopy on contemporary performance of urine cytology","volume":"124","author":"Freifeld","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.11.007_b0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.eururo.2025.03.018","article-title":"Use of the Xpert Bladder Cancer Monitor urinary biomarker test for guiding cystoscopy in high-grade non-muscle-invasive bladder cancer: results from the randomized controlled DaBlaCa-15 trial","volume":"88","author":"Dreyer","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.11.007_b0070","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.eururo.2019.04.035","article-title":"Evaluation of Cxbladder and adjudication of atypical cytology and equivocal cystoscopy","volume":"76","author":"Konety","year":"2019","journal-title":"Eur Urol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125002950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125002950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T20:57:35Z","timestamp":1775681855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931125002950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2588931125002950"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.11.007","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bladder EpiCheck triggered Photodynamic Diagnosis biopsies Detect High-grade Bladder Cancer Recurrences Missed by White Light Cystoscopy","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}